David_Westbrook_Anstice

David Anstice

David Anstice

Australian pharmaceutical executive and philanthropist

David Westbrook Anstice AO is a retired senior pharmaceutical executive and philanthropist.[1] Before retiring from Merck & Co in 2008 after a 34-year career with the company, Anstice played a key role in the global commercialisation of the HPV vaccine, which has significantly reduced cervical cancer incidence in young women.[1][2][3]

In 2018, Anstice was appointed an Officer of the Order of Australia for "distinguished service to Australia-America business relations, particularly in the pharmaceutical field, through roles with multinational and educational organisations."[4][5]

In April 2021, the University of Sydney awarded Anstice an honorary doctorate "in recognition of his outstanding contribution to business, education and the wider community."[2]

In August 2022, Anstice made a contribution of A$100,000 towards the digitisation of the historic scientific collections at the Australian Academy of Science.[1]

The University of Sydney has an Anstice MBA Scholarship for Community Leadership.[6]

Anstice lives in Pennsylvania, with his wife, Ana-Maria Zaugg.[3]

References

  1. [1]
    "Academy archive digitisation project boosted by generous donation". Australian Academy of Science. 2022-08-17. Retrieved 2023-07-06.
  2. [2]
    "David Anstice awarded honorary doctorate". The University of Sydney. Retrieved 2023-07-06.
  3. [3]
    "David Anstice". Advance The Global Australian Network. Retrieved 2023-07-10.
  4. [4]
    "OFFICER (AO) IN THE GENERAL DIVISION OF THE ORDER OF AUSTRALIA" (PDF). The Governor-General of the Commonwealth of Australia. Retrieved 6 July 2023.
  5. [5]
    "University of Sydney community honoured in Queen's birthday list". The University of Sydney. Retrieved 2023-07-06.
  6. [6]
    "Anstice MBA Scholarship for Community Leadership". The University of Sydney. Retrieved 2023-07-06.
Share this article:

This article uses material from the Wikipedia article David_Westbrook_Anstice, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.